+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Modeling the estrogen receptor to growth factor receptor signaling switch in human breast cancer cells



Modeling the estrogen receptor to growth factor receptor signaling switch in human breast cancer cells



Febs Letters 587(20): 3327-3334



Breast cancer cells develop resistance to endocrine therapies by shifting between estrogen receptor (ER)-regulated and growth factor receptor (GFR)-regulated survival signaling pathways. To study this switch, we propose a mathematical model of crosstalk between these pathways. The model explains why MCF7 sub-clones transfected with HER2 or EGFR show three GFR-distribution patterns, and why the bimodal distribution pattern can be reversibly modulated by estrogen. The model illustrates how transient overexpression of ER activates GFR signaling and promotes estrogen-independent growth. Understanding this survival-signaling switch can help in the design of future therapies to overcome resistance in breast cancer.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054415872

Download citation: RISBibTeXText

PMID: 23994522

DOI: 10.1016/j.febslet.2013.08.022


Related references

Estrogen receptor and receptor tyrosine kinase signaling: use of combinatorial hormone and epidermal growth factor receptor/human epidermal growth factor receptor 2-targeted therapies for breast cancer. Journal of Clinical Oncology 32(10): 1084-1086, 2014

Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells. Molecular Endocrinology 22(8): 1781-1796, 2008

Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells. Endocrinology 148(8): 4091-4101, 2007

Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Cancer Research 61(18): 6747-6754, 2001

Isolation of a heregulin-like growth factor secreted by estrogen receptor-negative MDA-MB-231 human breast cancer cells that stimulates estrogen receptor-positive cells. Biochemical and Biophysical Research Communications 202(3): 1357-1365, 1994

Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells. Journal of Biological Chemistry 273(16): 9994-10003, 1998

Improved antitumor therapy by dual targeting of estrogen and growth factor receptor signaling in human breast cancer cells. Journal of Clinical Oncology 24(18_suppl): 637-637, 2016

Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications. Breast Care 8(4): 256-262, 2014

Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators. Cancer ChemoTherapy and Pharmacology 56 Suppl 1: 10-20, 2005

Epidermal growth factor-induced signaling in breast cancer cells results in selective target gene activation by orphan nuclear receptor estrogen-related receptor alpha. Cancer Research 65(14): 6120-6129, 2005

Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004. Breast Journal 15(6): 593-602, 2010

Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer. Cancer Science 107(4): 491-498, 2016

Inverse relationship between estrogen receptor and epidermal growth factor receptor gene expression in human breast cancer cells. Proceedings Of The American Association For Cancer Research Annual Meeting: 7, 1988

Regulation of human estrogen receptor gene, epidermal growth factor receptor gene, and oncogenes by estrogen and antiestrogen in MCF-7 breast cancer cells. Cancer Detection and Prevention 13(2): 103-107, 1988

Transforming growth factor beta tgf beta binds to and inhibits estrogen receptor negative but not estrogen receptor positive human breast cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 28: 84, 1987